Sava Infond d.o.o. Invests $836,000 in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Sava Infond d.o.o. bought a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 9,280 shares of the exchange traded fund’s stock, valued at approximately $836,000.

A number of other hedge funds have also recently bought and sold shares of the company. Howard Capital Management Group LLC boosted its position in shares of SPDR S&P Biotech ETF by 2.6% during the 3rd quarter. Howard Capital Management Group LLC now owns 248,114 shares of the exchange traded fund’s stock valued at $24,514,000 after purchasing an additional 6,188 shares in the last quarter. Great Valley Advisor Group Inc. grew its position in SPDR S&P Biotech ETF by 28.0% in the third quarter. Great Valley Advisor Group Inc. now owns 3,414 shares of the exchange traded fund’s stock worth $337,000 after buying an additional 746 shares during the last quarter. Kingsview Wealth Management LLC increased its holdings in shares of SPDR S&P Biotech ETF by 8.2% in the third quarter. Kingsview Wealth Management LLC now owns 3,962 shares of the exchange traded fund’s stock valued at $391,000 after buying an additional 299 shares in the last quarter. Centaurus Financial Inc. acquired a new stake in shares of SPDR S&P Biotech ETF during the 3rd quarter valued at $416,000. Finally, Private Trust Co. NA boosted its stake in shares of SPDR S&P Biotech ETF by 476.3% during the 3rd quarter. Private Trust Co. NA now owns 2,916 shares of the exchange traded fund’s stock worth $288,000 after acquiring an additional 2,410 shares in the last quarter.

SPDR S&P Biotech ETF Trading Down 2.3 %

XBI stock opened at $85.08 on Thursday. The firm has a 50-day moving average of $89.52 and a two-hundred day moving average of $94.12. The firm has a market capitalization of $5.52 billion, a PE ratio of 11.47 and a beta of 0.99. SPDR S&P Biotech ETF has a one year low of $81.14 and a one year high of $105.47.

SPDR S&P Biotech ETF Cuts Dividend

The firm also recently announced a dividend, which was paid on Wednesday, March 26th. Stockholders of record on Monday, March 24th were issued a $0.0053 dividend. The ex-dividend date was Monday, March 24th.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.